研究・業績

英文論文

2017

  1. Sano K, Ichikawa T, Motosugi U, Ichikawa S, Morisaka H, Enomoto N, Matsuda M, Fujii H:Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis. Eur Radiol, 27 (2): 518-525. 2017. PubMedを見る»
  2. McClellan TR, Motosugi U, Middleton MS, Allen BC, Jaffe TA, Miller CM, Reeder SB, Sirlin CB, Bashir MR:Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial. Radiology, 282 (2): 361-368. 2017. PubMedを見る»
  3. Itazawa T, Tamaki Y, Komiyama T, Nishimura Y, Nakayama Y, Ito H, Ohde Y, Kusumoto M, Sakai S, Suzuki K, Watanabe H, Asamura H:The Japan Lung Cancer Society–Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer. Journal of Radiation Research, 58 (1): 86-105. 2017. PubMedを見る»
  4. Ichikawa S, Motosugi U, Omiya Y, Onishi H:Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid. Invest Radiol, 52 (7): 389-395. 2017.  PubMedを見る »
  5. Ichikawa S, Motosugi U, Oguri M, Onishi H:Magnetic resonance elastography for prediction of radiation-induced liver disease after stereotactic body radiation therapy. Hepatology, 66 (2): 664-665. 2017.  PubMedを見る »
  6. Motosugi U, Hernando D, Wiens C, Bannas P, Reeder SB:High SNR Acquisitions Improve the Repeatability of Liver Fat Quantification Using Confounder-corrected Chemical Shift-encoded MR Imaging. Magn Reson Med Sci, 16 (4): 332-339. 2017. [Epub ahead of print]   PubMedを見る »
  7. Motosugi U:Update Your Knowledge of Abdominal MRI: Recent Results, Which May Change Your Practice. Magn Reson Med Sci, 16 (2): 87-88. 2017.  PubMedを見る »
  8. Nishie A, Goshima S, Haradome H, Hatano E, Imai Y, Kudo M, Matsuda M, Motosugi U, Saitoh S, Yoshimitsu K, Crawford B, Kruger E, Ball G, Honda H:Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan. Clin Ther, 39 (4): 738-750 e4. 2017.   PubMedを見る »
  9. Morisaka H, Motosugi U, Glaser KJ, Ichikawa S, Ehman RL, Sano K, Ichikawa T, Onishi H:Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver. J Magn Reson Imaging, 45 (4): 1163-1170. 2017. PubMedを見る»
  10. Saito M, Kadoya N, Sato K, Ito K, Dobashi S, Takeda K, Onishi H, Jingu K:Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction. J Appl Clin Med Phys, 18 (4): 206-214. 2017.  PubMedを見る»
  11. Araki T, Imaizumi A, Okada H, Onishi H:Unusual Anatomical Variants of the Left Adrenal Vein via the Renal Capsular Vein Preventing Successful Adrenal Vein Sampling. Cardiovasc Intervent Radiol, 40 (8): 1296-1298. 2017.   PubMedを見る»
  12. Morisaka H, Motosugi U, Ichikawa S, Onishi H:Dose-dependence of transient respiratory motion artifacts on gadoxetic acid-enhanced arterial phase MR images. J Magn Reson Imaging, 2017.[Epub ahead of print]    PubMedを見る»
  13. Schubert T, Motosugi U, Kinner S, Colgan TJ, Sharma SD, Hetzel S, Wells S, Campo CA, Reeder SB:Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle. J Magn Reson Imaging, 45 (6): 1617-1626. 2017. PubMedを見る» 
  14. Ichikawa S, Motosugi U, Enomoto N, Matsuda M, Onishi H:Noninvasive hepatic fibrosis staging using mr elastography: The usefulness of the bayesian prediction method. J Magn Reson Imaging, 46 (2): 375-382. 2017. PubMedを見る»
  15. Ichikawa S, Motosugi U, Okumura A, Shimizu T, Onishi H:Measurement of Cerebrospinal Fluid Flow Dynamics Using Phase Contrast MR Imaging with Bilateral Jugular Vein Compression: A Feasibility Study in Healthy Volunteers. Magn Reson Med Sci, 2017. [Epub ahead of print]  PubMedを見る»
  16. Ichikawa S, Motosugi U, Hernando D, Morisaka H, Enomoto N, Matsuda M, Onishi H:Histological Grading of Hepatocellular Carcinomas with Intravoxel Incoherent Motion Diffusion-weighted Imaging: Inconsistent Results Depending on the Fitting Method. Magn Reson Med Sci, 2017. [Epub ahead of print]  PubMedを見る»
  17. Ichikawa S, Motosugi U, Oishi N, Shimizu T, Wakayama T, Enomoto N, Matsuda M, Onishi H:Ring-Like Enhancement of Hepatocellular Carcinoma in Gadoxetic Acid-Enhanced Multiphasic Hepatic Arterial Phase Imaging With Differential Subsampling With Cartesian Ordering. Invest Radiol, 2017. [Epub ahead of print]    PubMedを見る»
  18. Saito M, Sano N, Ueda K, Shibata Y, Kuriyama K, Komiyama T, Marino K, Aoki S, Onishi H:Evaluation of the latency and the beam characteristics of a respiratory gating system using an Elekta linear accelerator and a respiratory indicator device, Abches. Med Phys, 2017. [Epub ahead of print]  PubMedを見る»

 

2016

  1. Araki T, Okada H, Onishi H:Does catheter shape influence the success of right adrenal venous sampling? The interaction of catheter shape to anatomical factors on CT. Jpn J Radiol, 34 (11): 707-717. 2016. PubMedを見る»
  2. Motosugi U, Ichikawa T, Sano K, Onishi H:Acute Adverse Reactions to Nonionic Iodinated Contrast Media for CT: Prospective Randomized Evaluation of the Effects of Dehydration, Oral Rehydration, and Patient Risk Factors. AJR Am J Roentgenol, 207 (5): 931-938. 2016. PubMedを見る»
  3. Bannas P, Roldan-Alzate A, Johnson KM, Woods MA, Ozkan O, Motosugi U, Wieben O, Reeder SB, Kramer H:Longitudinal Monitoring of Hepatic Blood Flow before and after TIPS by Using 4D-Flow MR Imaging. Radiology, 281 (2): 574-582. 2016. PubMedを見る»
  4. Takamura T, Motosugi U, Ichikawa S, Sano K, Morisaka H, Ichikawa T, Enomoto N, Onishi H:Usefulness of MR elastography for detecting clinical progression of cirrhosis from child-pugh class A to B in patients with type C viral hepatitis. J Magn Reson Imaging, 44 (3): 715-22. 2016. PubMedを見る»
  5. Matsuda S, Motosugi U, Kato R, Muraoka M, Suzuki Y, Sato M, Shindo K, Nakayama Y, Inoue T, Maekawa S, Sakamoto M, Enomoto N:Hepatic Amyloidosis with an Extremely High Stiffness Value on Magnetic Resonance Elastography. Magn Reson Med Sci, 15 (3): 251-2. 2016.  PubMedを見る» 
  6. Satoh Y, Motosugi U, Nambu A, Saito A, Onishi H:Prognostic Value of Semiautomatic CT Volumetry in Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy. J Comput Assist Tomogr, 40 (3): 343-50. 2016. PubMedを見る»
  7. Siva S, Ellis RJ, Ponsky L, Teh BS, Mahadevan A, Muacevic A, Staehler M, Onishi H, Wersall P, Nomiya T, Lo SS:Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma. Future Oncol, 12 (5): 637-45. 2016. PubMedを見る»
  8. Chen N, Motosugi U, Morisaka H, Ichikawa S, Sano K, Ichikawa T, Matsuda M, Fujii H, Onishi H:Added Value of a Gadoxetic Acid-enhanced Hepatocyte-phase Image to the LI-RADS System for Diagnosing Hepatocellular Carcinoma. Magn Reson Med Sci, 15 (1): 49-59. 2016. PubMedを見る »
  9. Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB:An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology, 279 (1): 93-102. 2016. PubMedを見る »
  10. Bannas P, Motosugi U, Hernando D, Rahimi MS, Holmes JH, Reeder SB:Combined gadoxetic acid and gadofosveset enhanced liver MRI: A feasibility and parameter optimization study. Magn Reson Med, 75 (1): 318-28. 2016. PubMedを見る »
  11. Sciarra A, Di Tommaso L, Nakano M, Destro A, Torzilli G, Donadon M, Maggioni M, Bosari S, Bulfamante G, Matsuda M, Fujii H, Ichikawa T, Morisaka H, Sano K, Ichikawa S, Roncalli M:Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications. J Hepatol, 64 (1): 87-93. 2016. PubMedを見る »
  12. Bannas P, Bell LC, Johnson KM, Schiebler ML, Francois CJ, Motosugi U, Consigny D, Reeder SB, Nagle SK:Pulmonary Embolism Detection with Three-dimensional Ultrashort Echo Time MR Imaging: Experimental Study in Canines. Radiology, 278 (2): 413-21. 2016. PubMedを見る »
  13. Motosugi U, Bannas P, Hernando D, Salmani Rahimi M, Holmes JH, Reeder SB:Intraindividual Crossover Comparison of Gadoxetic Acid Dose for Liver MRI in Normal Volunteers. Magn Reson Med Sci, 15 (1): 60-72. 2016.  PubMedを見る »

2015

  1. Motosugi U:Gadoxetic Acid-induced Acute Transient Dyspnea: The Perspective of Japanese Radiologists. Magn Reson Med Sci, 14 (2): 163-4. 2015. PubMedを見る »
  2. Motosugi U, Hernando D, Bannas P, Holmes JH, Wang K, Shimakawa A, Iwadate Y, Taviani V, Rehm JL, Reeder SB:Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI. J Magn Reson Imaging, 42 (5): 1241-8. 2015 PubMedを見る »
  3. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL:Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol, 13 (3): 440-451 e6. 2015.  PubMedを見る »
  4. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Tatsumi A, Enomoto N, Matsuda M, Fujii H, Onishi H:Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn Reson Imaging, 33 (1): 26-30. 2015.   PubMedを見る »
  5. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H: Validity and reliability of magnetic resonance elastography for staging hepatic fibrosis in patients with chronic hepatitis B. Magn Reson Med Sci, 14(3):211-21. 2015.  PubMedを見る »

  6. Ichikawa S, Ichikawa T, Motosugi U, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H:Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images? Liver Cancer, 4 (3): 154-62. 2015. PubMedを見る »   
  7. Motosugi U, Bannas P, Sano K, Reeder SB:Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging, 41 (2): 251-65. 2015. PubMedを見る »
  8. Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, Enomoto N:Association of splenic MR elastographic findings with gastroesophageal varices in patients with chronic liver disease. J Magn Reson Imaging, 41 (1): 117-24. 2015. PubMedを見る »
  9. Ichikawa S, Motosugi U, Nakazawa T, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H:Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. J Magn Reson Imaging, 41 (5): 1203-8. 2015. PubMedを見る »
  10. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H:MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography.  J Magn Reson Imaging, 42 (1): 204-10. 2015.  PubMedを見る »
  11. Araki T, Okada H, Onishi H:Can microcatheters be cleaned for reuse after NBCA embolization? Cleaning technique with gelatin sponge particles. Jpn J Radiol, 33 (8): 509-16. 2015. PubMedを見る »
  12. Satoh Y, Koizumi K, Nambu A, Araki T:A Case of Massive Bone Metastases From Lung Cancer Detected Only by 18F-FDG PET/CT. Clin Nucl Med, 40 (8): e411-4. 2015. PubMed見る »
  13. Tominaga L, Onishi H, Kuriyama K, Araya M, Aoki S, Saito R, Maehata Y, Oguri M, Sato Y, Kato S:Prediction on Recurrence for Stage ⅠNon-Small Cell Lung Carcinoma by T1-SPECT and FDG-PET. Yamanashi Med J, 30 (20): 47-61. 2015.
  14. Maehata Y, Kuriyama K, Aoki S, Araya M, Marino K, Onishi H:Stereotactic Body Radiotherapy for Localized Ureter Transitional Cell Carcinoma: Three Case Reports. Case Rep Urol, 2015: 519897. 2015. PubMedを見る » 
  15. Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Onishi H:Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702). Radiother Oncol, 116 (2): 276-80. 2015. PubMedを見る »
  16. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K, Mitsuhashi N, Ishikura S:Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys, 93 (5): 989-96. 2015. PubMedを見る »

 

2014

  1. Matsuda M, Ichikawa T, Amemiya H, Maki A, Watanabe M, Kawaida H, Kono H, Sano K, Motosugi U, Fujii H:Preoperative gadoxetic Acid-enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection. HPB Surg, 2014: 641685. 2014. [Epub ahead of print] PubMedを見る »
  2. Satoh Y, Onishi H, Nambu A, Araki T:Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Radiology, 270 (1): 275-81. 2014. PubMedを見る »
  3. Matsuda M, Amemiya H, Kawaida H, Okamoto H, Hosomura N, Asakawa M, Sano K, Motosugi U, Ichikawa T, Nakazawa T, Fujii H:Typical fibrolamellar hepatocellular carcinoma in a Japanese boy: report of a case. Surg Today, 44 (7): 1359-66. 2014. PubMedを見る »
  4. Ichikawa T, Sano K, Morisaka H:Diagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current Consensus. Liver Cancer, 3 (2): 97-107. 2014. PubMedを見る »
  5. Ichikawa S, Ichikawa T, Motosugi U, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H, Araki T:Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. J Magn Reson Imaging, 39 (2): 293-7. 2014. PubMedを見る »
  6. Ichikawa S, Ichikawa T, Motosugi U, Imaizumi A, Sano K, Morisaka H:Computed Tomography (CT) Venography With Dual-Energy CT: Low Tube Voltage and Dose Reduction of Contrast Medium for Detection of Deep Vein Thrombosis. J Comput Assist Tomogr, 38 (5): 797-801. 2014. PubMedを見る »
  7. Fatima Z, Ichikawa T, Ishigame K, Motosugi U, Waqar AB, Hori M, Iijima H, Araki T:Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol, 24 (2): 129-34. 2014. PubMedを見る »
  8. Araki T, Okada H:Abdominal pressing maneuver during adrenal venous sampling for stabilization of catheter position. Cardiovasc Intervent Radiol, 37 (2): 498-501. 2014. PubMedを見る »
  9. Onishi H, Kawasaki T, Zakoji H, Yoshida T, Komiyama T, Kuriyama K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Marino K, Watanabe I, Oguri M, Araki T, Enomoto N, Takeda M, Katoh R:Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report. BMC Res Notes, 7: 270. 2014.  PubMedを見る »
  10. Satoh Y, Nambu A, Ichikawa T, Onishi H:Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. BMC Cancer, 14: 525. 2014. PubMedを見る »
  11. Shibamoto Y, Sumi M, Onodera S, Matsushita H, Sugie C, Tamaki Y, Onishi H, Abe E, Koizumi M, Miyawaki D, Kubota S, Ogo E, Nomiya T, Takemoto M, Harada H, Takahashi I, Ohmori Y, Ishibashi N, Tokumaru S, Suzuki K:Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. Int J Clin Oncol, 19 (5): 963-71. 2014.  PubMedを見る »

 

2013

  1. Shibamoto Y, Sumi M, Onodera S, Matsushita H, Sugie C, Tamaki Y, Onishi H, Abe E, Koizumi M, Miyawaki D, Kubota S, Ogo E, Nomiya T, Takemoto M, Harada H, Takahashi I, Ohmori Y, Ishibashi N, Tokumaru S, Suzuki K:Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. Int J Clin Oncol, 2013. [Epub ahead of print] PubMedを見る »
  2. Yamashita H, Niibe Y, Toita T, Kazumoto T, Nishimura T, Kodaira T, Eto H, Kinoshita R, Tsujino K, Onishi H, Takemoto M, Hayakawa K:High-dose-rate Intra-cavitary Brachytherapy Combined with External Beam Radiation Therapy for Under 40-Year-old Patients with Invasive Uterine Cervical Carcinoma: Clinical Outcomes in 118 Patients in a Japanese Multi-institutional Study, JASTRO. Jpn J Clin Oncol, 43 (5): 547-52. 2013. PubMedを見る »
  3. Watanabe M, Onishi H, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga R, Oguri J, Sano N, Araki T:Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors. J Radiat Res, 54 (4): 762-8. 2013. PubMedを見る »
  4. Onishi H, Araki T:Stereotactic body radiation therapy for stage I non-small-cell lung cancer: a historical overview of clinical studies. Jpn J Clin Oncol, 43 (4): 345-50. 2013. PubMedを見る »
  5. Niibe Y, Chang JY, Onishi H, Salama J, Hiraki T, Yamashita H:Oligometastases/Oligo-recurrence of lung cancer. Pulm Med, 2013: 438236. 2013. PubMedを見る »
  6. Nambu A, Onishi H, Aoki S, Tominaga L, Kuriyama K, Araya M, Saito R, Maehata Y, Komiyama T, Marino K, Koshiishi T, Sawada E, Araki T:Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors. BMC Cancer, 13: 68. 2013. PubMedを見る »
  7. Muhi A, Ichikawa T, Motosug U, Sano K, Fatima Z, Matsuda M, Fujii H, Enomoto N, Araki T:Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy. Hepatol Int, 7 (2): 662-8. 2013.
  8. Motosugi U, Ichikawa T, Koshiishi T, Sano K, Morisaka H, Ichikawa S, Enomoto N, Matsuda M, Fujii H, Araki T:Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case-control study. Eur Radiol, 23 (1): 156-62. 2013. PubMedを見る »
  9. Motosugi U, Ichikawa T, Araki T, Matsuda M, Fujii H, Enomoto N:Bayesian prediction for liver fibrosis staging: Combined use of elastography and serum fibrosis markers. Hepatology, 58 (1): 450-1. 2013. PubMedを見る »
  10. Motosugi U:Hypovascular hypointense nodules on hepatocyte phase gadoxetic acid-enhanced MR images: too early or too progressed to determine hypervascularity. Radiology, 267 (1): 317-8. 2013. PubMedを見る »
  11. Motosgui U, Ichikawa T, Araki T:Rules, Roles, and Room for Discussion in Gadoxetic Acid-enhanced Magnetic Resonance Liver Imaging: Current Knowledge and Future Challenges. Magn Reson Med Sci, 12 (3): 161-75. 2013. PubMedを見る »
  12. Morisaka H, Motosugi U, Ichikawa T, Sano K, Ichikawa S, Araki T, Enomoto N:MR-based Measurements of Portal Vein Flow and Liver Stiffness for Predicting Gastroesophageal Varices. Magn Reson Med Sci, 12 (2): 77-86. 2013. PubMedを見る »
  13. Matsuo Y, Onishi H, Nakagawa K, Nakamura M, Ariji T, Kumazaki Y, Shimbo M, Tohyama N, Nishio T, Okumura M, Shirato H, Hiraoka M:Guidelines for respiratory motion management in radiation therapy. J Radiat Res, 54 (3): 561-8. 2013. PubMedを見る »
  14. Maehata Y, Onishi H, Kuriyama K, Aoki S, Araya M, Saito R, Tominaga L, Oguri M, Araki T:Immune responses following stereotactic body radiotherapy for stage I primary lung cancer. Biomed Res Int, 2013: 731346. 2013. PubMedを見る »
  15. Isohashi F, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Uno T, Ito Y, Karasawa K, Takayama M, Manabe Y, Yamazaki H, Takemoto M, Yoshioka Y, Nemoto K, Nishimura Y:Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey. Radiat Oncol, 8: 76. 2013. PubMedを見る »
  16. Igaki H, Onishi H, Nakagawa K, Dokiya T, Nemoto K, Shigematsu N, Nishimura Y, Hiraoka M:A newly introduced comprehensive consultation fee in the national health insurance system in Japan: a promotive effect of multidisciplinary medical care in the field of radiation oncology–results from a questionnaire survey. Jpn J Clin Oncol, 43 (12): 1233-7. 2013. PubMedを見る »
  17. Ichikawa T, Okada M, Kondo H, Sou H, Murakami T, Kanematsu M, Yoshikawa S, Shiosakai K, Hayakawa A, Awai K, Yoshimitsu K, Yamashita Y:Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan. Acad Radiol, 20 (9): 1130-6. 2013. PubMedを見る »
  18. Ichikawa T, Motosugi U, Morisaka H, Sano K, Muhi A, Araki T:Volumetric low-tube-voltage CT imaging for evaluating hypervascular hepatocellular carcinoma; effects on radiation exposure, image quality, and diagnostic performance. Jpn J Radiol, 31 (8): 521-9. 2013. PubMedを見る »
  19. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Araki T:Intravoxel incoherent motion imaging of focal hepatic lesions. J Magn Reson Imaging, 37 (6): 1371-6. 2013. PubMedを見る »
  20. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Araki T:Intravoxel incoherent motion imaging of the kidney: alterations in diffusion and perfusion in patients with renal dysfunction. Magn Reson Imaging, 31 (3): 414-7. 2013. PubMedを見る »
  21. Fatima Z, Motosugi U, Waqar AB, Hori M, Ishigame K, Oishi N, Onodera T, Yagi K, Katoh R, Araki T:Associations among q-space MRI, diffusion-weighted MRI and histopathological parameters in meningiomas. Eur Radiol, 23 (8): 2258-63. 2013. PubMedを見る »
  22. Fatima Z, Motosugi U, Muhi A, Hori M, Ishigame K, Araki T:Diffusion-weighted imaging in optic neuritis. Can Assoc Radiol J, 64 (1): 51-5. 2013. PubMedを見る »
  23. Fatima Z, Motosugi U, Hori M, Onodera T, Ishigame K, Yagi K, Araki T:Age-related white matter changes in high b-value q-space diffusion-weighted imaging. Neuroradiology, 55 (3): 253-9. 2013. PubMedを見る »
  24. Fatima Z, Ishigame K, Araki T:Case 193. Radiology, 266 (1): 355-6. 2013. PubMedを見る »
  25. Fatima Z, Ishigame K, Araki T:Case 193: Neuroferritinopathy–a brain iron accumulation and neurodegenerative disorder. Radiology, 267 (2): 650-5. 2013. PubMedを見る »
  26. Chen N, Motosugi U, Sano K, Ichikawa T, Nakano M, Morisaka H, Ichikawa S, Matsuda M, Fujii H, Enomoto N, Araki T:Early hepatocellular carcinomas showing isointensity or hyperintensity in gadoxetic Acid-enhanced, hepatocyte-phase magnetic resonance images. J Comput Assist Tomogr, 37 (3): 466-9. 2013. PubMedを見る »
  27. Araki T, Okada H:Enhancement of ascites during abdominal oncological endovascular intervention without iatrogenic extravasation in patients with chronic liver disease. Clin Radiol, 68 (8): e460-6. 2013. PubMedを見る »

2012

  1. Onishi H, Ozaki M, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Oguri M, Watanabe I, Onohara K, Watanabe M, Sano N, Araki T:Stereotactic body radiotherapy for metachronous multisite oligo-recurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature. Pulm Med, 2012: 713073. 2012. PubMedを見る »
  2. Satoh Y, Nambu A, Onishi H, Sawada E, Tominaga L, Kuriyama K, Komiyama T, Marino K, Aoki S, Araya M, Saito R, Maehata Y, Oguri M, Araki T:Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. Eur J Radiol, 81 (11): 3530-4. 2012. PubMedを見る »
  3. Onishi H, Ozaki M, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tomiaga L, Oguri M, Watanabe I, Onohara K, Sano N, Araki T:Serious gastric ulcer event after stereotactic body radiotherapy (SBRT) delivered with concomitant vinorelbine in a patient with left adrenal metastasis of lung cancer. Acta Oncologica, 51 (5): 624-8. 2012. PubMedを見る »
  4. Onishi H, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Sano N, Oguri M, Onohara K, Watanabe I, Koshiishi T, Ogawa K, Araki T:Large prostate motion produced by anal contraction. Radiother Oncol, 104 (3): 390-4. 2012. PubMedを見る »
  5. Ogawa K, Ito Y, Hirokawa N, Shibuya K, Kokubo M, Ogo E, Shibuya H, Saito T, Onishi H, Karasawa K, Nemoto K, Nishimura Y:Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. Int J Radiat Oncol Biol Phys, 83 (2): 559-65. 2012. PubMedを見る »
  6. Muhi A, Ichikawa T, Motosugi U, Sou H, Sano K, Tsukamoto T, Fatima Z, Araki T:Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging, 35 (4): 827-36. 2012. PubMedを見る »
  7. Muhi A, Ichikawa T, Motosugi U, Sou H, Sano K, Araki T:Diffusion- and T2 -weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium. Magn Reson Med Sci, 11 (3): 185-91. 2012. PubMedを見る »
  8. Muhi A, Ichikawa T, Motosugi U:Gadoxetic acid-enhanced MRI:a method for the detection of hepatic metastases. Imaging Med, 4 (3): 279-86. 2012.
  9. Motosugi U, Yamaguchi H, Furukawa T, Ichikawa T, Hatori T, Fujita I, Yamamoto M, Motoi F, Kanno A, Watanabe T, Koike N, Koyama I, Kobayashi J, Shimizu M:Imaging Studies of Intraductal Tubulopapillary Neoplasms of the Pancreas: 2-Tone Duct Sign and Cork-of-Wine-Bottle Sign as Indicators of Intraductal Tumor Growth. J Comput Assist Tomogr, 36 (6): 710-17. 2012. PubMedを見る »
  10. Motosugi U, Ichikawa T, Sou H, Sano K, Muhi A, Ehman RL, Araki T:Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography. Magn Reson Imaging, 30 (1): 128-32. 2012. PubMedを見る »
  11. Motosugi U, Ichikawa T, Sou H, Morisaka H, Sano K, Araki T:Multi-organ perfusion CT in the abdomen using a 320-detector row CT scanner: Preliminary results of perfusion changes in the liver, spleen, and pancreas of cirrhotic patients. Eur J Radiol, 81 (10): 2533-7. 2012. PubMedを見る »
  12. Motosugi U, Ichikawa T, Muhi A, Sano K, Morisaka H, Ichikawa S, Araki T:Magnetic resonance elastography as a predictor of insufficient liver enhancement on gadoxetic acid-enhanced hepatocyte-phase magnetic resonance imaging in patients with type C hepatitis and Child-Pugh class A disease. Invest Radiol, 47 (10): 566-70. 2012. PubMedを見る »
  13. Motosugi U, Ichikawa T, Amemiya F, Sou H, Sano K, Muhi A, Enomoto N, Araki T:Cross-validation of MR elastography and ultrasound transient elastography in liver stiffness measurement: discrepancy in the results of cirrhotic liver. J Magn Reson Imaging, 35 (3): 607-10. 2012. PubMedを見る »
  14. Ichikawa T, Motosugi U, Morisaka H, Sou H, Onohara K, Sano K, Araki T:Optimal iodine dose for 3-dimensional multidetector-row CT angiography of the liver. Eur J Radiol, 81 (9): 2450-5. 2012. PubMedを見る »
  15. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H, Araki T:Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci, 11 (4): 291-7. 2012. PubMedを見る »
  16. Haradome H, Grazioli L, Al manea K, Tsunoo M, Motosugi U, Kwee TC, Takaraha T:Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging, 35 (1): 132-9. 2012. PubMedを見る »
  17. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, Donato F, Colagrande S:Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology, 262 (2): 520-9. 2012. PubMedを見る »
  18. Fatima Z, Motosugi U, Okumura A, Ishigame K, Araki T:Basi-parallel Anatomical Scanning (BPAS)-MRI Can Improve Discrimination of Vertebral Artery Dissection from Atherosclerosis and Hypoplasia. Acad Radiol, 19 (11): 1362-7. 2012. PubMedを見る »
  19. Fatima Z, Motosugi U, Hori M, Ishigame K, Onodera T, Yagi K, Araki T:High b-Value q-Space Analyzed Diffusion-Weighted MRI Using 1.5 Tesla Clinical Scanner; Determination of Displacement Parameters in the Brains of Normal versus Multiple Sclerosis and Low-Grade Glioma Subjects. J Neuroimaging, 22 (3): 279-84. 2012. PubMedを見る »
  20. Araki T, Saad WE:Balloon-occluded retrograde transvenous obliteration of gastric varices from unconventional systemic veins in the absence of gastrorenal shunts. Tech Vasc Interv Radiol, 15 (3): 241-53. 2012. PubMedを見る »

2011

  1. Satoh Y, Ichikawa T, Motosugi U, Kimura K, Sou H, Sano K, Araki T:Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol, 196 (2): 447-53. 2011. PubMedを見る »
  2. Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, Matsuda M, Nakano M, Sakamoto M, Nakazawa T, Asakawa M, Fujii H, Kitamura T, Enomoto N, Araki T:Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology, 261 (3): 834-44. 2011. PubMedを見る »
  3. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T:Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys, 81 (5): 1352-8. 2011. PubMedを見る »
  4. Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Araya M, Mukumoto N, Teshima T, Mitsumori M:Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey. Int J Radiat Oncol Biol Phys, 81 (5): 1310-8. 2011. PubMedを見る »
  5. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y:Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys, 80 (1): 111-8. 2011. PubMedを見る »
  6. Nambu A, Sawada E, Kato S, Araki T, Aikawa Y, Yuge M, Saito A:Determination of a standard deviation that could minimize radiation exposure in an automatic exposure control for pulmonary thin-section computed tomography. Japanese Journal of  Radiology, 29 (6): 405-12. 2011. PubMedを見る »
  7. Nambu A, Onishi H, Aoki S, Koshiishi T, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Tominaga L, Maehata Y, Sawada E, Araki T:Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patients. Radiat Oncol, 6: 137. 2011. PubMedを見る »
  8. Nakazawa T, Kondo T, Yuminomochi T, Nakazawa K, Ishii Y, Mochizuki K, Kawasaki T, Yamane T, Miyata M, Motosugi U, Katoh R:Fine-needle aspiration biopsy of low-grade cribriform cystadenocarcinoma of the salivary gland. Diagn Cytopathol, 39 (3): 218-22. 2011. PubMedを見る »
  9. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T:Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging, 34 (2): 326-35. 2011. PubMedを見る »
  10. Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, Muhi A, Kitamura T, Amemiya F, Enomoto N, Matsuda M, Asakawa M, Fujii H, Araki T:Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol, 46 (2): 141-5. 2011. PubMedを見る »
  11. Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, Muhi A, Amemiya F, Enomoto N, Matsuda M, Fujii H, Araki T:Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease. Journal of  Magnetic Resonance Imaging, 34 (1): 88-94. 2011. PubMedを見る »
  12. Motosugi U, Ichikawa T, Onohara K, Sou H, Sano K, Muhi A, Araki T:Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Investigative Radiology, 46 (6): 359-65. 2011. PubMedを見る »
  13. Motosugi U, Ichikawa T, Oguri M, Sano K, Sou H, Muhi A, Matsuda M, Fujii H, Enomoto N, Araki T:Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging, 29 (8): 1047-52. 2011. PubMedを見る »
  14. Motosugi U, Ichikawa T, Niitsuma Y, Araki T:Acoustic radiation force impulse elastography of the liver: can fat deposition in the liver affect the measurement of liver stiffness? Jpn J Radiol, 29 (9): 639-43. 2011. PubMedを見る »
  15. Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K, Sano K, Araki T:Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology, 260 (2): 446-53. 2011. PubMedを見る »
  16. Hori M, Motosugi U, Fatima Z, Kumagai H, Ikenaga S, Ishigame K, Aoki S, Onodera T, Yagi K, Araki T:A comparison of mean displacement values using high b-value Q-space diffusion-weighted MRI with conventional apparent diffusion coefficients in patients with stroke. Acad Radiol, 18 (7): 837-41. 2011. PubMedを見る »
  17. Hori M, Motosugi U, Fatima Z, Ishigame K, Araki T:Mean displacement map of spine and spinal cord disorders using high b-value q-space imaging-feasibility study. Acta Radiol, 52 (10): 1155-8. 2011. PubMedを見る »
  18. Haradome H, Grazioli L, Tinti R, Morone M, Motosugi U, Sano K, Ichikawa T, Kwee TC, Colagrande S:Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging. J Magn Reson Imaging, 34 (1): 69-78. 2011. PubMedを見る »
  19. Fatima Z, Ichikawa T, Motosugi U, Muhi A, Sano K, Sou H, Haradome H, Kiryu S, Araki T:Magnetic resonance diffusion-weighted imaging in the characterization of pancreatic mucinous cystic lesions. Clin Radiol, 66 (2): 108-11. 2011. PubMedを見る »